• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重和肥胖的囊性纤维化患者体重与肺部预后的关系:一项回顾性观察研究。

The relationship between weight and pulmonary outcomes in overweight and obese people with cystic fibrosis: A retrospective observational study.

作者信息

Welter John J, Lennox Alison T, Krishnan Sankaran, Kim Christy, Krishnan Sheila, Thompson Haley, McAllister Emily, Huang Kristen, Nwaedozie Kasiemobi, Dozor Allen J

机构信息

Division of Pediatric Pulmonology New York Medical College Valhalla New York USA.

Touro College of Osteopathic Medicine New York New York USA.

出版信息

Health Sci Rep. 2022 Oct 28;5(6):e910. doi: 10.1002/hsr2.910. eCollection 2022 Nov.

DOI:10.1002/hsr2.910
PMID:36320654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9616171/
Abstract

BACKGROUND

A major focus in cystic fibrosis (CF) care aims to increase weight gain. Rates of overweight and obese people with CF have gradually increased over the past decade. Obesity could be a risk for restriction of lung volumes and airway obstruction as well as increase rates of pulmonary exacerbations in people with CF.

AIM

To assess the relationship between weight categories and pulmonary outcomes in children and adults with CF.

METHODS

Patients 6 years of age and older were categorized into weight categories based on the Centers for Disease Control and Prevention (CDC) definitions. A retrospective chart review was conducted to obtain lung function testing and other outcomes.

RESULTS

One hundred five patients with a median age of 20.6 years were included in this analysis. 8.4%, 64%, 18%, and 10% of patients were underweight, normal/healthy weight, overweight, and obese, respectively. Forced expiratory volume in 1 s (FEV) and forced vital capacity (FVC) (% predicted) did not differ between patients with weights in the normal range versus patients in the overweight/obese categories. Linear regression analysis showed a direct correlation between body mass index (BMI) and FEV that continued as BMI entered overweight and obese categories in both pediatric and adult patients. Overweight/obese patients did not have increased rates of pulmonary exacerbations compared to those in the normal/healthy weight category.

CONCLUSION

As CF therapies continue to improve, an increasing number of people with CF are exceeding the CDC's normal-weight range. Gaining weight past the normal range does not appear to negatively impact pulmonary health of people with CF. If this trend of increased weight gain continues, it remains to be seen if it will eventually negatively affect lung health.

摘要

背景

囊性纤维化(CF)护理的一个主要重点是增加体重。在过去十年中,CF患者中超重和肥胖人群的比例逐渐上升。肥胖可能会导致肺容量受限和气道阻塞,同时增加CF患者肺部急性加重的发生率。

目的

评估CF儿童和成人的体重类别与肺部结局之间的关系。

方法

根据美国疾病控制与预防中心(CDC)的定义,将6岁及以上的患者分为不同的体重类别。通过回顾性病历审查来获取肺功能测试和其他结局。

结果

本分析纳入了105例患者,中位年龄为20.6岁。分别有8.4%、64%、18%和10%的患者体重过轻、体重正常/健康、超重和肥胖。体重在正常范围内的患者与超重/肥胖类别的患者相比,1秒用力呼气量(FEV)和用力肺活量(FVC)(预测值%)没有差异。线性回归分析显示,在儿童和成人患者中,体重指数(BMI)与FEV之间存在直接相关性,且随着BMI进入超重和肥胖类别这种相关性依然存在。与体重正常/健康类别的患者相比,超重/肥胖患者的肺部急性加重发生率并未增加。

结论

随着CF治疗方法不断改进,越来越多的CF患者体重超过了CDC的正常体重范围。体重超过正常范围似乎不会对CF患者的肺部健康产生负面影响。如果体重增加的这种趋势持续下去,最终是否会对肺部健康产生负面影响还有待观察。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9616171/b5e074dfc957/HSR2-5-e910-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9616171/90d24d0453c3/HSR2-5-e910-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9616171/737cbbbc2056/HSR2-5-e910-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9616171/b5e074dfc957/HSR2-5-e910-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9616171/90d24d0453c3/HSR2-5-e910-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9616171/737cbbbc2056/HSR2-5-e910-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52f3/9616171/b5e074dfc957/HSR2-5-e910-g001.jpg

相似文献

1
The relationship between weight and pulmonary outcomes in overweight and obese people with cystic fibrosis: A retrospective observational study.超重和肥胖的囊性纤维化患者体重与肺部预后的关系:一项回顾性观察研究。
Health Sci Rep. 2022 Oct 28;5(6):e910. doi: 10.1002/hsr2.910. eCollection 2022 Nov.
2
[Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].[体重指数及胸部CT特征在慢性阻塞性肺疾病评估中的价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020 Feb 28;42(1):55-61. doi: 10.3881/j.issn.1000-503X.11206.
3
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
4
Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.常规胸部物理治疗与其他气道清除技术在囊性纤维化中的比较。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD002011. doi: 10.1002/14651858.CD002011.pub3.
5
Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis.囊性纤维化成人超重和肥胖的患病率及相关因素:一项单中心分析。
J Cyst Fibros. 2020 Jan;19(1):139-145. doi: 10.1016/j.jcf.2019.10.004. Epub 2019 Nov 11.
6
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
7
Atopy and pulmonary function among healthy-weight and overweight/obese children with asthma.特应性与哮喘健康体重和超重/肥胖儿童的肺功能。
Pediatr Pulmonol. 2021 Jan;56(1):34-41. doi: 10.1002/ppul.25005. Epub 2020 Oct 27.
8
Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors.成年囊性纤维化患者超重、肥胖和显著体重增加与肺功能和心血管代谢危险因素有关。
Clin Nutr. 2020 Sep;39(9):2910-2916. doi: 10.1016/j.clnu.2019.12.029. Epub 2020 Jan 10.
9
Body mass index increase: a risk factor for forced expiratory volume in 1 s decline for overweight and obese adults with asthma.体重指数增加:超重和肥胖哮喘成年人1秒用力呼气量下降的一个风险因素。
ERJ Open Res. 2022 Oct 24;8(4). doi: 10.1183/23120541.00110-2022. eCollection 2022 Oct.
10
The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.基于网络的项目对学龄儿童肥胖症减轻的有效性:一项系统评价。
JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248.

引用本文的文献

1
Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry.依列卡福妥/替扎卡福妥/依伐卡托对囊性纤维化患者肺功能、营养状况、肺部恶化频率及汗液氯化物的影响:来自德国囊性纤维化登记处的真实世界证据
Lancet Reg Health Eur. 2023 Jul 28;32:100690. doi: 10.1016/j.lanepe.2023.100690. eCollection 2023 Sep.

本文引用的文献

1
Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis.囊性纤维化成人超重和肥胖的患病率及相关因素:一项单中心分析。
J Cyst Fibros. 2020 Jan;19(1):139-145. doi: 10.1016/j.jcf.2019.10.004. Epub 2019 Nov 11.
2
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.依伐卡托与泰比卡托和艾克卡托三联复方药物治疗携带单个 F508del 突变的囊性纤维化
N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.
3
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
在纯合子 F508del 突变的囊性纤维化患者中,elexacaftor 加 tezacaftor 加 ivacaftor 联合治疗方案的疗效和安全性:一项双盲、随机、3 期临床试验。
Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31.
4
Energy balance and obesity in individuals with cystic fibrosis.囊性纤维化患者的能量平衡与肥胖。
J Cyst Fibros. 2019 Oct;18 Suppl 2:S38-S47. doi: 10.1016/j.jcf.2019.08.015.
5
Obesity and asthma.肥胖与哮喘。
J Allergy Clin Immunol. 2018 Apr;141(4):1169-1179. doi: 10.1016/j.jaci.2018.02.004.
6
Body mass index status and peripheral airway obstruction in school-age children: a population-based cohort study.学龄儿童体重指数状况与外周气道阻塞:基于人群的队列研究。
Thorax. 2018 Jun;73(6):538-545. doi: 10.1136/thoraxjnl-2017-210716. Epub 2018 Jan 29.
7
Overweight, Obesity, and Lung Function in Children and Adults-A Meta-analysis.超重、肥胖与儿童和成人的肺功能——一项荟萃分析。
J Allergy Clin Immunol Pract. 2018 Mar-Apr;6(2):570-581.e10. doi: 10.1016/j.jaip.2017.07.010. Epub 2017 Sep 28.
8
Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.囊性纤维化相关糖尿病(CFRD)之前会出现生长发育迟缓,并与肺功能恶化相关。
J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):815-821. doi: 10.1515/jpem-2017-0005.
9
Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment.婴幼儿囊性纤维化:疾病表现、进展及早期治疗反应的综述。
J Cyst Fibros. 2016 Mar;15(2):147-57. doi: 10.1016/j.jcf.2015.09.008. Epub 2015 Oct 9.
10
Overweight-mortality paradox and impact of six-minute walk distance in lung transplantation.超重-死亡率悖论及六分钟步行距离在肺移植中的影响
Ann Thorac Med. 2015 Jul-Sep;10(3):169-75. doi: 10.4103/1817-1737.160835.